Lipocine Inc.LPCNNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank21
3Y CAGR-2.5%
5Y CAGR-14.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-2.5%/yr
vs -6.4%/yr prior
5Y CAGR
-14.5%/yr
Recent acceleration
Acceleration
+3.9pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$3.76M-24.7%
2024$5.00M+2.0%
2023$4.90M+20.7%
2022$4.06M-23.8%
2021$5.33M-35.4%
2020$8.25M+47.4%
2019$5.60M+5.8%
2018$5.29M-48.2%
2017$10.21M-1.6%
2016$10.38M-